InsiderTrades.com logo
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

MODD Insider Trading

Insider Ownership Percentage: 59.20%
Insider Buying (Last 12 Months): $46,400.00
Insider Selling (Last 12 Months): $0.00

Modular Medical Insider Trading History Chart

This chart shows the insider buying and selling history at Modular Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Modular Medical Share Price & Price History

Current Price: $1.30
Price Change: ▲ Price Increase of +0.07 (5.69%)
As of 11/28/2023 01:00 AM ET

This chart shows the closing price history over time for MODD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

Modular Medical Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/1/2023Philip Brent SheibleyDirectorBuy10,000$1.29$12,900.0046,139View SEC Filing Icon  
10/16/2023Manchester Management Co LlcDirectorBuy20,000$1.10$22,000.00144,750View SEC Filing Icon  
9/12/2023Philip Brent SheibleyDirectorBuy10,000$1.15$11,500.0033,639View SEC Filing Icon  
7/26/2022Philip Brent SheibleyDirectorBuy2,000$4.12$8,240.0010,139View SEC Filing Icon  
3/15/2022Paul DipernaInsiderBuy10,000$4.00$40,000.00View SEC Filing Icon  
2/10/2022Manchester Management Co LlcDirectorBuy300,000$6.00$1,800,000.00View SEC Filing Icon  
See Full Table
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for Modular Medical (NASDAQ:MODD)

29.42% of Modular Medical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at MODD by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Modular Medical Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/14/2023Perritt Capital Management Inc.40,000$46K0.0%N/A0.190%Search for SEC Filing on Google Icon
8/15/2023Citadel Advisors LLC28,249$28K0.0%N/A0.134%Search for SEC Filing on Google Icon
8/14/2023683 Capital Management LLC938,966$0.92M0.1%N/A4.452%Search for SEC Filing on Google Icon
2/10/2023Opaleye Management Inc.245,000$0.49M0.2%-11.0%2.242%Search for SEC Filing on Google Icon
8/15/2022Opaleye Management Inc.275,422$1.43M0.6%+3.5%2.524%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC24,365$0.13M0.0%-33.2%0.223%Search for SEC Filing on Google Icon
8/15/2022Sio Capital Management LLC574,352$2.98M1.1%N/A5.263%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Modular Medical logo
Modular Medical, Inc. operates as a development stage medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for diabetes. The company was founded in 1998 and is headquartered in San Diego, California.
Read More on Modular Medical

Today's Range

Now: $1.30
Low: $1.15
High: $1.30

50 Day Range

MA: $1.11
Low: $0.92
High: $1.30

52 Week Range

Now: $1.30
Low: $0.84
High: $3.84

Volume

11,673 shs

Average Volume

42,896 shs

Market Capitalization

$27.46 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Modular Medical?

Modular Medical's top insider shareholders include:
  1. Manchester Management Co Llc (Director)
  2. Philip Brent Sheibley (Director)
  3. Paul Diperna (Insider)
Learn More about top insider investors at Modular Medical.

Who are the major institutional investors of Modular Medical?

Modular Medical's top institutional investors include:
  1. Perritt Capital Management Inc. — 0.19%
Learn More about top institutional investors of Modular Medical stock.

Which institutional investors are buying Modular Medical stock?

Within the previous quarter, MODD stock was bought by institutional investors including:
  1. Perritt Capital Management Inc.
During the previous year, these company insiders have bought Modular Medical stock:
  1. Manchester Management Co Llc (Director)
  2. Philip Brent Sheibley (Director)
  3. Paul Diperna (Insider)
Learn More investors buying Modular Medical stock.
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.